Insider Selling: Arteris, Inc. (NASDAQ:AIP) Director Sells 41,439 Shares of Stock

by · The Cerbat Gem

Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Saiyed Atiq Raza sold 41,439 shares of Arteris stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $10.37, for a total value of $429,722.43. Following the transaction, the director now owns 690,121 shares in the company, valued at approximately $7,156,554.77. The trade was a 5.66 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Saiyed Atiq Raza also recently made the following trade(s):

  • On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The shares were sold at an average price of $10.07, for a total value of $122,511.62.
  • On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total transaction of $24,024.00.

Arteris Stock Up 0.8 %

Shares of NASDAQ AIP traded up $0.08 during midday trading on Monday, hitting $10.35. The company’s stock had a trading volume of 261,787 shares, compared to its average volume of 169,906. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market capitalization of $415.83 million, a price-to-earnings ratio of -10.78 and a beta of 1.25. The business’s fifty day simple moving average is $8.50 and its two-hundred day simple moving average is $7.95. Arteris, Inc. has a 1 year low of $4.83 and a 1 year high of $10.69.

Hedge Funds Weigh In On Arteris

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. US Bancorp DE acquired a new stake in shares of Arteris in the third quarter valued at $34,000. Renaissance Technologies LLC increased its holdings in Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after purchasing an additional 6,600 shares during the period. MetLife Investment Management LLC raised its position in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of Arteris in the 2nd quarter valued at about $86,000. Finally, Franklin Resources Inc. grew its position in shares of Arteris by 0.8% during the third quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company’s stock worth $11,201,000 after buying an additional 12,375 shares in the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Read Our Latest Stock Analysis on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More